SCHEMBL2649617

SCHEMBL2649617

CCN(CC)CCNCc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 4/20 0.53
▸ SCN8A Q9UQD0 1/20 0.52
▸ SLC6A4 P31645 3/20 0.48
▸ SLC6A3 Q01959 2/20 0.48
▸ TSHR P16473 1/20 0.44
▸ EPHX2 P34913 2/20 0.42
▸ NR1H4 Q96RI1 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313153 0.96 MCHR1 (0.50) MCHR1SCN8ASLC6A4SLC6A3TSHR
SCHEMBL16268473 0.85 SCN8A (0.54) MCHR1SCN8ASLC6A4SLC6A3TSHR
SCHEMBL2650572 0.83 SLC6A4 (0.46) MCHR1SCN8ASLC6A4SLC6A3TSHR
SCHEMBL3542034 0.82 CACNA1B (0.49) MCHR1SCN8AEPHX2
Hydrochloric Acid SCHEMBL8446857 0.81 SCN8A (0.57) SCN8ATSHREPHX2NR1H4ALDH1A1
SCHEMBL10889965 0.80 MCHR1 (0.60) MCHR1SLC6A4SLC6A3EPHX2L3MBTL1
SCHEMBL13992690 0.79 KDM4E (0.45) MCHR1EPHX2ALDH1A1SMN1; SMN2CHRM2
SCHEMBL3962793 0.79 SCN8A (0.54) SCN8ASLC6A4TSHREPHX2NR1H4
SCHEMBL8348550 0.79 SCN8A (0.55) SCN8ATSHREPHX2NR1H4ALDH1A1
SCHEMBL5765031 0.78 S1PR2 (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613942-B1 Nonpeptide; 4-hydroxy benzoic acid hydrazides NOVO NORDISK A/S (DK) 2003-09-02 — — US disclosed
EP-0994848-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 2000-04-26 — — EP disclosed
WO-1999001423-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 1999-01-14 — — WO disclosed
WO-1999001423-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 1999-01-14 — — WO disclosed
Send feedback